Cortexyme (CRTX) News Today → How Biden has already won 2024 (From Porter & Company) (Ad) Free CRTX Stock Alerts $0.91 -0.01 (-1.09%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsInsider TradesSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCortexyme (NASDAQ:CRTX) Stock Passes Above 200-Day Moving Average of $1.12americanbankingnews.com - May 1 at 3:04 AMCortexyme : Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name - Form 8-K - Marketscreener.commarketscreener.com - August 1 at 11:24 AMCortexyme Completes Phase 1 Single, Multiple Ascending Dose Trial of Potential Alzheimer's Disease Treatment - Marketscreener.commarketscreener.com - July 27 at 3:47 PMCortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 - Business Wirebusinesswire.com - July 27 at 3:47 PMCortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 - Business Wirebusinesswire.com - July 27 at 3:47 PMCortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 - Marketscreener.commarketscreener.com - July 27 at 10:45 AMCortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 - Yahoo Financefinance.yahoo.com - July 27 at 10:45 AMCortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588finance.yahoo.com - July 27 at 10:44 AMCortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022finance.yahoo.com - July 27 at 10:44 AMCortexyme (CRTX) Announces Resignation of EVP of Research and Development - StreetInsider.comstreetinsider.com - July 22 at 10:41 PMBragar Eagel & Squire, PC Is Investigating Agrify, CareDx, Medallion, and Cortexyme and Encourages Investors to Contact the Firm - GuruFocus.comgurufocus.com - June 26 at 2:17 AMCortexyme Announces Preclinical Data Demonstrating Efficacy Of Cor803 For The Treatment Of Coronavirus In - Benzingabenzinga.com - June 21 at 11:52 AMCortexyme : Preclinical Data Show Efficacy Of COR803 For Coronavirus Infections Treatment - Nasdaqnasdaq.com - June 21 at 11:52 AMCortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infectionsfinance.yahoo.com - June 21 at 11:52 AMCortexyme Appoints June Bray to its Board of Directors - Business Wirebusinesswire.com - June 13 at 3:34 PMCortexyme Appoints June Bray to its Board of Directors - Yahoo Financefinance.yahoo.com - June 13 at 10:33 AMCortexyme Appoints June Bray to its Board of Directorsfinance.yahoo.com - June 13 at 10:33 AMCortexyme, Inc. Announces Resignation of Christopher Lowe as Chief Financial Officer - Marketscreener.commarketscreener.com - June 11 at 12:50 PMCortexyme : Statement of Changes in Beneficial Ownership (Form 4) - Marketscreener.commarketscreener.com - June 10 at 4:48 PMCortexyme Successfully Completes Acquisition of Novosteo - Business Wirebusinesswire.com - May 22 at 5:27 PMThis Is the Worst Type of Credit Card for Most Consumers - Nasdaqnasdaq.com - May 20 at 5:28 PMPPG Showcases Innovations in Paints, Coatings, Specialty Materials That Enhance Sustainability, Efficiency, Mobility - Yahoo Financefinance.yahoo.com - May 20 at 9:21 AMCortexyme : Completion of Acquisition or Disposition of Assets - Form 8-K - Marketscreener.commarketscreener.com - May 20 at 9:21 AMCortexyme Successfully Completes Acquisition of Novosteo - Yahoo Financefinance.yahoo.com - May 20 at 9:21 AMCortexyme Appoints Dr. Philip Low to Its Board of Directorsfinance.yahoo.com - May 20 at 9:21 AMPre-market Movers: EBET, AFRM, CELU, FIGS, LLAP… - Nasdaqnasdaq.com - May 13 at 3:32 PMCortexyme to Participate at 4th International Conference on Porphyromonas gingivalis and Related Species in Oral and Systemic Diseases - Yahoo Financefinance.yahoo.com - May 12 at 10:14 AMCortexyme to Participate at 4th International Conference on Porphyromonas gingivalis and Related Species in Oral and Systemic Diseasesfinance.yahoo.com - May 12 at 10:14 AMForm 10-Q Cortexyme, Inc. For: Mar 31 - StreetInsider.comstreetinsider.com - May 11 at 1:09 AMCortexyme Announces Agreement to Acquire Novosteo - StreetInsider.comstreetinsider.com - May 11 at 1:09 AMTuesday Digest: Prologis attempts hostile buyout of Duke; Salesforce's latest buy - San Francisco Business Times - The Business Journalsbizjournals.com - May 10 at 2:57 PMCortexyme Announces Agreement to Acquire Novosteofinance.yahoo.com - May 10 at 9:56 AMBragar Eagel & Squire, P.C. Is Investigating Agrify, CareDx, Medallion, and Cortexyme and Encourages Investors to Contact the Firmbenzinga.com - May 6 at 9:43 PMIs Cortexyme (NASDAQ:CRTX) In A Good Position To Deliver On Growth Plans?finance.yahoo.com - May 6 at 3:29 PMBragar Eagel & Squire, PC Is Investigating CareDx, Medallion, Cortexyme, and Corcept and Encourages Investors to Contact the Firm - GuruFocus.comgurufocus.com - May 3 at 11:39 PMThe Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Appl - Benzingabenzinga.com - May 3 at 1:35 PMCortexyme Announces Further Layoffs, Chief Medical Officer Leavesbenzinga.com - May 3 at 10:17 AMCORTEXYME, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K) - Marketscreener.commarketscreener.com - May 3 at 1:08 AMBragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and Corcept and Encourages Investors to Contact the Firmbenzinga.com - May 1 at 9:38 PMCortexyme, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Benzingabenzinga.com - April 28 at 1:44 PMBragar Eagel & Squire, P.C. Is Investigating Cortexyme, Corcept, RBB, and Verra and Encourages Investors to Contact the Firmbenzinga.com - April 25 at 9:12 PMThinking about buying stock in Cortexyme, Borqs Technologies, Sundial Growers, Nokia, or Nordic American Tanker? - PR Newswireprnewswire.com - April 25 at 3:19 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cortexyme, Inc. - CRTX - Benzingabenzinga.com - April 23 at 9:08 PMBragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and SelectQuote and Encourages Investors to Contact the Firmbenzinga.com - April 15 at 9:28 PMBragar Eagel & Squire, PC Is Investigating CareDx, Medallion, Cortexyme, and SelectQuote and Encourages Investors to Contact the Firm - GlobeNewswireglobenewswire.com - April 15 at 9:03 PMBragar Eagel & Squire, P.C. Is Investigating Medallion, Cortexyme, SelectQuote, and Corcept and Encourage - Benzingabenzinga.com - April 11 at 10:31 AMBragar Eagel & Squire, PC Is Investigating Medallion, - GlobeNewswireglobenewswire.com - April 10 at 11:33 PMCortexyme (NASDAQ:CRTX) Downgraded to "Sell" at Zacks Investment Researchmarketbeat.com - March 29 at 8:15 PMHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Cortexyme, Inc. (CRTX) For Possible Securities Law Violations, Encourages Investors With Significant Losses to Contact Firm - GlobeNewswireglobenewswire.com - March 28 at 6:26 PMBragar Eagel & Squire, PC Is Investigating Sea, - GlobeNewswireglobenewswire.com - March 27 at 12:11 PM Get Cortexyme News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here CRTX Media Mentions By Week CRTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRTX News Sentiment▼0.000.36▲Average Medical News Sentiment CRTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRTX Articles This Week▼00▲CRTX Articles Average Week Get Cortexyme News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IN8bio News Protara Therapeutics News MiNK Therapeutics News Surrozen News NKGen Biotech News Achilles Therapeutics News Pluri News Brainstorm Cell Therapeutics News SAB Biotherapeutics News Dyadic International News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRTX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cortexyme, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
